Boeing enters its July 28 earnings date in a notably different position than six months ago — short sellers are quietly stepping back, borrowing costs have halved, and the analyst consensus has tilted increasingly constructive, even as the stock digests a 1.2% dip on Tuesday after a 7% weekly gain.
The most telling shift in the lending market is how rapidly the bear trade has unwound. Short interest, running above 16.7 million shares in early June, has pulled back to around 14.3 million — roughly 1.9% of the free float. That's a 10% decline month-on-month and represents the lowest conviction short book Boeing has seen in months. Availability remains extraordinarily loose, with over 6,200% of current short interest sitting in the lending pool — effectively an unlimited borrow environment. Cost to borrow has followed suit, dropping roughly 31% over the past month to just 0.32%, near the cheapest level in the past six weeks. For a stock that spent much of 2023-2024 carrying a meaningful short premium, the borrow market now reflects almost no institutional urgency to press the short side. The ORTEX short score of 31.1 is consistent with that picture — sitting well below the midpoint and edging lower through the week.
Options positioning reinforces the lack of defensive lean. The put/call ratio at 0.80 is running just below its 20-day average of 0.82 — a mild tilt toward calls relative to recent norms. This is the lowest PCR reading since May, and well off the defensive peaks above 1.03 seen earlier in the year. With the 52-week low PCR at 0.72, there's room for positioning to get more bullish, but the current setup reads as moderately constructive rather than crowded with optimism.
The Street's direction of travel has been uniformly upward for months. The most recent changes — with Morgan Stanley lifting its target to $250 and Citigroup raising to $260 in the April-May window — reflect a cadence of incremental target increases rather than bold re-ratings. The mean price target now stands at $270, implying roughly 17% upside from current levels. Against a trailing P/E of 123x, valuation remains elevated in absolute terms, but the EV/EBITDA of 31.8x has actually compressed by more than 1.3x over the past month — one sign the market is beginning to price in a recovery in operating earnings rather than simply paying up for the story. The factor scores reinforce the bull case on momentum: EPS momentum over both 30 and 90 days ranks in the 94th-98th percentile, a reflection of sharply improving forward estimates. The weak link remains EPS surprise at just the 10th percentile — Boeing has a recent history of missing relative to the optimistic consensus, which frames what matters most on July 28.
The institutional picture shows BlackRock adding over 4.2 million shares in the most recently reported quarter through June, while Fidelity added 3.7 million in the same period. That is meaningful demand from the two largest holders at a time when the stock was in the mid-$200s. The insider ledger is less conclusive — CEO Kelly Ortberg sold around $1.2 million worth of stock in February at $236, though all significance scores attached to those February trades were rated at the lowest level, suggesting largely routine or programmatic transactions rather than directional signals.
The last earnings print on April 22 produced a 6.8% single-day gain. That reaction, following a quarter where Boeing signalled progress on 737 MAX production rates, set the tone for the stock's 7.5% monthly gain. The question on July 28 is whether delivery momentum and margin recovery can stay ahead of a consensus that has already moved the target north by roughly $25 per share since January — making the bar measurably higher than it was last quarter.
See the live data behind this article on ORTEX.
Open BA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
